[Evaluation of the activity of duxil in the endocochlear hypoacusis of ischemic origin].
Soubeyrand
L
L
Institution Nationale des Invalides, Paris.
Bordes
L R
LR
Blondin
P
P
D000328:Adult; D000368:Aged; D015765:Almitrine; D001299:Audiometry; D003051:Cochlea / Q000098:blood supply* / Q000503:physiopathology; D004338:Drug Combinations / Q000627:therapeutic use; D005072:Evoked Potentials, Auditory; D005260:Female; D006311:Hearing Disorders / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007511:Ischemia / Q000150:complications*; D007759:Labyrinth Diseases / Q000209:etiology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D015016:Yohimbine / Q000627:therapeutic use*
D004338:Drug Combinations; D010879:Piperazines; D015016:Yohimbine; C037558:almitrine, raubasine drug combination; D015765:Almitrine
Evaluation de l'activité de duxil dans les hypoacousies endocochléaires d'origine ischémique.